Novartis’ Anti-Arthritis Drug Lumiracoxib (Prexige), Recalled From Philippine Market
Here in the Philippines, the Bureau of Food and Drugs has ordered the pull-out from the market of the pain-killer anti-arthritis drug – Lumiracoxib (Prexige) by Novartis - due to fears that it can cause liver damage.
In November 2007, Novartis announced that Prexige had been suspended from sale and marketing in Britain and Germany amid fears it can cause liver damage.


I would like the patients to understand their condition better in order to help them discern what is best for their life with arthritis in conjunction to what their doctors are telling them! .. 
